You are here:

budesonide (Pulmicort)


Following an abbreviated submission

budesonide CFC-free inhaler (Pulmicort) is accepted for use in NHS Scotland for the treatment of asthma.

Budesonide CFC-free inhaler (Pulmicort) (hydrofluoroalkanes [HFA] pressurised metered dose inhaler [pMDI]) replaces the equivalent CFC-containing pMDI formulations at a similar cost per microgram.

Drug Details

Drug Name: budesonide (Pulmicort)
SMC Drug ID: 536/09
Manufacturer: AstraZeneca UK Ltd
Indication: Asthma
BNF Category:
Sub Category: 3.2 Corticosteroids
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 14 April 2009